PTC Therapeutics
PTCT
PTCT
176 hedge funds and large institutions have $2.63B invested in PTC Therapeutics in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
3.83%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.2%
New
30
Increased
65
Reduced
57
Closed
26
Calls
$19.2M
Puts
$14.2M
Net Calls
+$5.03M
Net Calls Change
+$3.98M
Top Buyers
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$32.7M |
| 2 |
Millennium Management
New York
|
+$31.3M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$30.8M |
| 4 |
RI
RTW Investments
New York
|
+$28M |
| 5 |
O
OrbiMed
New York
|
+$25.7M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$50.5M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$40.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$38.3M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$24.9M |
| 5 |
Renaissance Technologies
New York
|
-$24.2M |
